Hoover Financial Advisors’s GSK GSK Stock Holding History

Hoover Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$190K	Hold	3,821	–	–	0.03%	140
2021 Q1	$182K	Sell	3,821 -1,828	-32%	-$83K	0.03%	133
2020 Q4	$269K	Hold	5,649	–	–	0.07%	86
2020 Q3	$266K	Hold	5,649	–	–	0.09%	77
2020 Q2	$288K	Hold	5,649	–	–	0.11%	73
2020 Q1	$268K	Sell	5,649 -800	-12%	-$42.7K	0.15%	61
2019 Q4	$379K	Hold	6,449	–	–	0.18%	62
2019 Q3	$344K	Sell	6,449 -3,442	-35%	-$177K	0.31%	38
2019 Q2	$495K	Buy	9,891 +3,621	+58%	+$182K	0.46%	31
2019 Q1	$328K	Sell	6,270 -5,504	-47%	-$275K	0.31%	40
2018 Q4	$562K	Buy	+11,774	New	+$580K	0.62%	22

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hoover Financial Advisors's GSK Position: Q2 2021 in Review

Hoover Financial Advisors held its GSK (GSK) position steady in Q2 2021 at 3,821 shares worth $190K. The position accounts for 0.03% of the portfolio, ranked #140.

Hoover Financial Advisors first reported a position in GSK in Q4 2018 and has held it in 11 quarters since. The position peaked at $562K in Q4 2018. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

Hoover Financial Advisors held 3,821 shares of GSK worth $190K as of Q2 2021.
Hoover Financial Advisors left its GSK share count unchanged in Q2 2021.
GSK made up 0.03% of Hoover Financial Advisors's portfolio in Q2 2021, its #140 holding.
Hoover Financial Advisors first reported a position in GSK in Q4 2018 and has held it in 11 quarters since.
Hoover Financial Advisors's GSK position peaked at $562K in Q4 2018.
798 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.